CHAPTER 3: THE MORAL ECONOMY OF THE AVAILABILITY OF THERAPEUTICINNOVATIONS FOR NEGLECTED DISEASES
DOI:
https://doi.org/10.54695/jib.29.02.3495Keywords:
Drugs, patents, health care costs, vulnerable populations, resource allocation,Neglected diseasesAbstract
The main problems of the system governing the development and dissemination of innovative medicines are known. Despite relatively low manufacturing costs, patented drugsare unduly expensive, and neglected diseases attract little pharmaceutical research. Bothproblems are compounded by patients who, discouraged by high prices, lack of access tocompetent medical services and low quality medicines, do not complete their treatment
Published
2018-07-20
How to Cite
TROUILLER, P. (2018). CHAPTER 3: THE MORAL ECONOMY OF THE AVAILABILITY OF THERAPEUTICINNOVATIONS FOR NEGLECTED DISEASES. Journal International De bioéthique Et d’éthique Des Sciences, 29(02). https://doi.org/10.54695/jib.29.02.3495
Issue
Section
Articles
